Amicus Therapeutics, Inc. Income Statement

1Y3Y5Y7Y10YAll
Download Data
Income Statement Dec2009 Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 64.36M0.92M21.43M18.41M0.36M1.22M-1.58M4.96M36.93M91.25M182.24M260.89M305.51M329.23M399.36M528.29M
Cost of Revenue 0.83M6.24M14.40M21.96M31.04M34.47M38.60M37.33M52.94M
Gross Profit 64.36M0.92M21.43M18.41M0.36M1.22M-1.58M4.12M30.69M76.84M160.27M229.84M271.05M290.63M362.03M475.35M
Operating items
Depreciation & Amortization - Total 1.55M1.83M3.24M3.60M4.20M4.50M8.40M5.70M4.80M4.80M5.00M
Research & Development 48.08M39.04M50.86M50.27M41.94M47.62M76.94M104.79M149.31M270.90M286.38M308.44M272.05M276.68M152.38M109.36M
Selling, General & Administrative 19.97M15.66M19.88M19.36M18.89M20.72M47.27M71.15M88.67M127.20M169.86M156.41M192.71M213.04M275.27M323.38M
Restructuring Costs 1.52M1.52M1.99M-0.06M0.01M0.07M9.19M
Other Operating Expenses 2.13M0.54M1.58M-49.81M-61.80M-0.10M-4.38M-6.76M234.32M-3.30M-3.30M-3.14M-6.51M-1.08M-2.58M3.55M
Operating Expenses 71.71M56.76M72.32M71.34M64.54M69.92M130.44M186.01M472.68M405.62M464.31M476.84M477.48M502.75M439.24M450.48M
Operating Income -7.35M-55.84M-50.89M-52.93M-64.18M-68.70M-130.44M-181.89M-441.99M-328.78M-304.04M-247.00M-206.43M-212.12M-77.21M24.88M
EBIT -7.35M-55.84M-50.89M-52.93M-64.18M-68.70M-130.44M-181.89M-441.99M-328.78M-304.04M-247.00M-206.43M-212.12M-77.21M24.88M
Non-operating items
Non Operating Investment Income -2.74M
Interest & Investment Income 1.00M0.16M0.16M0.32M0.17M0.22M0.93M1.60M4.10M10.46M10.25M3.23M0.51M3.02M7.08M5.41M
Other Non Operating Income -0.45M1.41M0.07M0.02M-0.08M-0.08M-4.79M6.01M-5.63M-2.63M-7.28M-2.90M4.18M-15.89M-9.44M
Non Operating Income 0.06M1.28M0.07M0.02M-0.08M-0.08M-4.79M6.01M-5.63M-2.63M-0.78M-2.90M4.18M-15.89M-9.44M
Net income details
EBT -6.57M-56.08M-48.04M-52.03M-63.15M-70.04M-132.12M-203.78M-449.12M-349.09M-355.91M-274.25M-241.55M-242.04M-150.10M-28.76M
Tax Provisions 0.69M-1.14M-3.63M-3.25M-3.51M-1.11M-3.74M-165.12M-0.09M0.48M2.60M8.91M-5.47M1.48M27.35M
Profit After Tax -6.57M-54.94M-44.41M-48.78M-59.63M-68.93M-132.12M-200.04M-284.00M-349.00M-356.39M-276.85M-250.46M-236.57M-151.58M-56.11M
Income from Continuing Operations -7.26M-54.94M-44.41M-48.78M-59.63M-68.93M-132.12M-200.04M-284.00M-349.00M-356.39M-276.85M-250.46M-236.57M-151.58M-56.11M
Consolidated Net Income -7.26M-54.94M-44.41M-48.78M-59.63M-68.93M-132.12M-200.04M-284.00M-349.00M-356.39M-276.85M-250.46M-236.57M-151.58M-56.11M
Income towards Parent Company -7.26M-54.94M-44.41M-48.78M-59.63M-68.93M-132.12M-200.04M-284.00M-349.00M-356.39M-276.85M-250.46M-236.57M-151.58M-56.11M
Net Income towards Common Stockholders -6.57M-54.94M-44.41M-48.78M-59.63M-68.93M-132.12M-200.04M-284.00M-349.00M-356.39M-276.85M-250.46M-236.57M-151.58M-56.11M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 22.65M27.64M34.65M49.45M49.63M79.32M124.90M142.33M166.27M189.29M254.81M260.59M278.64M280.95M293.25M298.81M
Shares Outstanding (Diluted Average) 240.42M258.87M271.42M289.06M295.16M304.38M
EBITDA -7.35M-55.84M-50.89M-52.93M-64.18M-67.15M-128.60M-178.65M-438.38M-324.58M-299.54M-238.60M-200.73M-207.32M-72.41M29.88M
Tax Rate 2.03%7.55%6.24%5.56%1.59%1.83%36.76%0.03%2.26%